DOP86 Risk for development of inflammatory bowel disease under inhibition of interleukin 17 in psoriasis, psoriatic arthritis, ankylosing spondylitis, and rheumatoid arthritis: a review and meta-analysis
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.